bermakna antara kadar albumin dengan hemisfer otak yang terkena, lapisan otak yang terkena, ukuran infark dan jumlah infark.
11. Secara keseluruhan
outcome penderita stroke iskemik yang dinilai dengan BI adalah
sedang skor BI antara 60 – 85 dan outcome baik skor MRS 4 bila dinilai dengan MRS.
12. Tidak ada hubungan yang bermakna antara kadar albumin serum dengan outcome
fungsional penderita stroke iskemik baik dengan diabetes maupun tanpa diabetes.
V.2. Saran
Perlu dilakukan penelitian lebih lanjut dengan skala yang lebih besar dengan jumlah subjek yang lebih banyak sehingga diperoleh hasil yang lebih representatif.
Roberthus Bangun: Hubungan Kadar Albumn Serum Dan Outcome Fungsional Penderita Stroke Iskemik Dengan Dan Tanpa Diabetes, 2008.
DAFTAR PUSTAKA
Adams, H.P., del Zoppo, G., Alberts, M.J., Bhatt, D.L., Brass, L., Furlan, A., et al. 2007. Guidelines for the Early Management of Adults With Ischemic Stroke. A Guideline From the American
Heart AssociationAmerican Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral
Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke. 38:1655 – 1711.
Ahmed, S.H., Hu, C., Paczynski, R., Hsu, C.Y. 2001. Pathophysiology of Ischemic Injury. In: Fisher, M., ed. Stroke Theraphy. pp.25 – 57. Butterworth-Heinemann. Boston.
Air, E.L., and Kissela, B.M. 2007. Diabetes, the Metabolic Syndrome and Ischemic Stroke: Epidemiology and Possible Mechanisms. Diabetes Care. 36:1735 – 1742.
Almdal, T., Scharling, H., Jensen, J.S., Vestergaard, H. 2004. The Independent Effect of Type 2 Diabetes Mellitus on Ischemic Heart Disease, Stroke, and Death. A Population-Based Study
of 13000 Man and Woman With 20 Years of Follow-up. Arch Intern Med. 164: 1422 – 1426. Banks, J.L., Marotta, C.A. 2007. Outcomes Validity and Reliability of Modified Rankin Scale:
Implications for Stroke Clinical Trials. A Literature Riview and Synthesis. Stroke. 38:1091 – 1096.
Beckman, J.A., Creager, M.A., Libby, P. 2002. Diabetes and Atherosclerosis. Epidemiology, Pathophysiology, and Management. JAMA. 287:2570 – 2581.
Belayev, L., Liu, Y., Zhao, W., Busto, R., Ginsberg, M.D. 2001. Human Albumin Therapy of Acute
Ischemic Stroke. Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window. Stroke. 32:553 – 560.
Belayev, L., Pinard, E., Nallet, H., Seylaz, J., Liu, Y., Riyamongkol, P., et al. 2002. Albumin Therapy of Transient Focal Cerebral Ischemia. In Vivo Analysis of Dynamic Microvascular
Responses. Stroke. 33:1077 – 1084. Belayev, L., Marcheselli, V.L., Khoutorova, L., Rodriguez de Turco, E.B., Busto, R., Ginsberg,
M.D., et al. 2005. Decosahexaenoic Acid Complexed to Albumin Elicits High-Grade Ischemic Neuroprotection. Stroke. 36:118 – 123.
Bhalla, A., Wolfe, C.D.A., Ruud, A.G. 2001. Management of acute physiological parameters after stroke.
Q J Med . 94:167 – 172.
Blecic, S.A and Devuyst, G. 2001. General Management of Acute Stroke. In: Fisher, M., ed. Stroke Theraphy. pp.211 – 224. Butterworth-Heinemann. Boston.
Roberthus Bangun: Hubungan Kadar Albumn Serum Dan Outcome Fungsional Penderita Stroke Iskemik Dengan Dan Tanpa Diabetes, 2008.
Broderick, J.P., Broot, T.G., Duldner, J.E. 1993. Volume of Intracranial Haemorrhage of Powerful and Easy to Use. Predictor of 30 Days Mortality. Stroke. 24::987 – 993.
Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., et al. 2007. Guideline for the Management of Spontaneous Intracerebral Hemorrhage in Adult 2007 Update. A
Guideline From the American Heart Association American Stroke Association Stroke Council, High Blood Preassure Council and the Quality of Care and Outcomes in Reseach
InterdisciplinaryWorking Group. Stroke. 38:2001 – 2023.
Bruno, A., Biller, J., Adam, H.P Jr., Clarke, W.R., Woolson, R.F., Williams, L.S., Hansen, M.D. 1999. Acute blood glucose level and outcome from ischemic stroke. Trial of org 10172 in
acute stroke treatment TOAST investibators. Neurology. 52:280 – 284. Calles-Escandon, J dan Cipolla, M. 2001. Diabetes and Endothelial Dysfuction: A Clinical
Perspective. Endocrine Reviews. 221:36 – 52. Capes, S.E., Hunt, D., Malmberg, K., Pathak, P., Gerstein, H.C. 2001. Stress Hyperglycemia and
Prognosis of Stroke in Nondiabetic and Diabetic Patients. A Systematic Overview. Stroke. 32:2426 – 2432.
Caplan, L.R. 2000. Caplan’s Stroke: A clinical Approach. 3
rd
ed. Butterworth-Heinemmann. Boston. Castaneda, C., Bermudez, O.I., Tucker, K.L. 2000. Protein nutritional status ang function are
associated with type 2 diabetes in Hispanic elders. The American Journal of Clinical Nutrition. 72:89 – 95.
Davis, J.P., Wong, A.A., Schluter, P.J., Henderson, R.D., O’Sullivan, J.D., Read, S.J. 2004. Impact of Premorbid Undernutrition on Outcome in Stroke patients. Stroke. 35:1930 – 1934.
Davis, S.M. 2001. Endpoint and Statistical Concerns for Acute Stroke Therapy Trials. In: Fisher, M., ed. Stroke Theraphy. pp.123 – 134. Butterworth-Heinemann. Boston.
Davalos, A., Ricart, W., Gonzales-Huix, F., Soler, S., Marrugat, J., Molins, A., Suner, R., Ganis, NND. 1996. Effect of Malnutrition After Acute Stroke on Clinical Outcome. Stroke. 27:1028 –
1032. De Freitas, G.R., Bezerra, D.C., Maulaz, A.B., Bogousslavsky, J. 2005. Stroke: background,
epidemiology, etiology and avoiding recurrence. In: Barnes, M., Dobkin, B., Bogousslavsky, J., eds. Recovery after Stroke. pp.1 – 46. Cambridge University Press. Cambridge.
DeFronzo, R.A. 2005. Diabetic Nephropathy. In: Inzucchi, S., Porte, D., Sherwin, R.S., Baron, A. eds. The Diabetes Mellitus Manual: A Primary Care Companion to Ellenberg Rifkin’s. 6
th
ed. pp.325 – 346. McGraw-Hill. New York. Departemen Neurologi RSUP H. Adam Malik Medan, 2006. Data penderita rawat inap tahun 2006.
Roberthus Bangun: Hubungan Kadar Albumn Serum Dan Outcome Fungsional Penderita Stroke Iskemik Dengan Dan Tanpa Diabetes, 2008.
Dziedzic, T., Slowik, A., and Szczudlik, A. 2004. Serum Albumin Level as a Predictor of Ischemic Stroke Outcome. Stroke.35:156 – 158.
Eguchi, K., Kario, K., Shimada, K. 2003. Greater Impact of Coexistence of Hypertension and Diabetes on Silent Cerebral Infarcts. Stroke. 34:2471 – 2474.
Eppens, M.C., Craig, M.E., Cusumano, J., Hing, S., Chan, A.K.F., Howard, N.J., Silink, M., Donaghue, K.C. 2006. Prevalence of Diabetes Complication in Adolesents With Type 2
Compared With Type 1 Diabetes. Diabetes Care. 29:1300 – 1306. Fitzsimmons, B.M. 2007. Cerebrovascular Disease: Ischemic Stroke. In: Brust, J.C.M., ed.
Current Diagnosis and Treatment in Neurology. pp.100 – 125. Mc Graw Hill. New York. FOOD Trial Collaboration. 2003. Poor Nutritional Status on Admission Predicts Poor Outcome
After Stroke. Observational Data From the FOOD Trial. Stroke. 34:1450 – 1456. Garg, R., Chaudhuri, A., Munschauer, F., Dandona, P. 2006. Hyperglicemia, Insulin, and Acute
Ischemic Stroke. A Mechanistic Justification for a Trial of Insulin Infusion Theraphy. Stroke. 37:267 – 273.
Gilroy, J. Basic Neurology. 2000. 3rd ed. McGraw-Hill. New York. Gentile, N.T., Seftchick, M.W., Huynh, T., Kruus, L.K., Gaughan, J. 2006. Decreased Mortality by
Mormalizing Blood Glucose after Acute Ischemic Stroke. Academic Emergency Medicine. 13:174 – 180.
Ginsberg, M.D. 2003. Adventures in the Pathophysiology of Brain Ischemia: Penumbra, Gene Expression, Neuroprotection. The 2002 Thomas Willis Lecture. Stroke. 34:214 – 223.
Ginsberg, M.D., Hill, M.D., Palesch, Y.Y., Ryckborst, K., Tamariz, D. 2006. The ALIAS Pilot Trial. A dose-Escalation and Safety of Albumin Therapy for Acute Ischemic Stroke – I: Physiological
Responses and Safety Results. Stroke. 37:2100 – 2106. Goldstein, L.B., Adams, R., Alberts, M.J., Appel, L.J., Brass, L.M., Bushnell, C.D., et al. Primary
Prevention of Ischemic Stroke: A Guideline From the American Heart AssociationAmerican Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular
Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and
Outcomes Research Interdisciplinary Working Group. Stroke. 37:1583 – 1633.
Gray, C.S., Scott, J.F., French, J.M., Alberti, K.G.M.M., O’Connel, J.E. 2004. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute
stroke. Age and Aging. 33:71 – 77.
Roberthus Bangun: Hubungan Kadar Albumn Serum Dan Outcome Fungsional Penderita Stroke Iskemik Dengan Dan Tanpa Diabetes, 2008.
Hacke, W., Kaste, M., Bogousslavsky, J., Brainin, M., Gugging, M., Chamorro, A., Lees, K., Leys,
D., Kwiecinski, H., Toni, D. 2003. European Stroke Initiative : Ischemic Stroke Prophylaxis and Treatment. EUSI. Heidelberg.
Hankey, G.J., Lees, K.R. 2001. Stroke Management in Practice. Mosby International Limited. London.
Harmsen, P., Lappas, G., Rosengren, A., Wilhelmsen, L. 2006. Long Term Risk Factors for Stroke. Twenty – Eight Years of Follow-Up of 7457 Middle-Aged Med in Goteborg, Sweden. Stroke.
37:1663 – 1667. Hu, G., Sarti, C., Jousilahti, P., Peltonen, M., Quiao, Q., Antikainen, R., et al. 2005. The Impact of
History of Hypertension and Type 2 Diabetes at Baseline on the Incidenceof Stroke and Stroke Mortality. Stroke. 36:2538 – 2543.
Inzucchi, S.E. 2005. Classification and Diagnosis of Diabetes Mellitus. In: Inzucchi, S., Porte, D., Sherwin, R.S., Baron, A. eds. The Diabetes Mellitus Manual: A Primary Care Companion to
Ellenberg Rifkin’s. 6
th
ed. pp. 1 – 14. McGraw-Hill. New York. Janghorbani, M., Hu, F.B., Willet W.C. Li, T.Y., Manson, J.E., Logroscino, G., Rexrode, K.M. 2007.
Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes. Diabetes Care. 30: 1730 – 1735.
Jannis, J. 2007. Pengantar Computerized Tomography CT scan. In: Rasyid, A., Soertidewi, L. eds. Unit Stroke. Manajemen Stroke Secara Komprehensif. pp. 109 – 115. Balai Penerbit
Universitas Indonesia. Jakarta. Jhonson, M.H. and Kubal, W.S. 1999. Stroke. In: Lee, S.h., Rao, K.C.V.G. AND Zimmermann,
R.A. eds Cranial MRI and CT. 4th ed. pp. 557 – 598. McGraw-Hill. New York. Kagansky, N., Levy, S,. Knobler, H. 2001. The Role of Hyperglycemia in Acute Stroke. Arch
Neurol. 58:1209 – 1212. Khan, S.E dan Porte, D. 2005. The Pathophysiology and Genetics of Type 2 Diabetes Mellitus. In:
Inzucchi, S., Porte, D., Sherwin, R.S., Baron, A. eds. The Diabetes Mellitus Manual: A Primary Care Companion to Ellenberg Rifkin’s. 6
th
ed. pp.51 – 75. McGraw-Hill. New York. Kelly-Hayes, M., Robertson, J.T., Broderick, J.P., Duncan, P.W., Hershey, L.A., Roth, E.J., et al.
1998. The American Heart Association Stroke Outcome Classification. Stroke. 29:1274 – 1280.
Kelompok Studi Serebrovaskuler Neurogeriatri Perdossi. 1999. Guideline Stroke 2000. Seri pertama. Jakarta.
Roberthus Bangun: Hubungan Kadar Albumn Serum Dan Outcome Fungsional Penderita Stroke Iskemik Dengan Dan Tanpa Diabetes, 2008.
ketiga. Jakarta. Kirshner, H.S., Biller, J., Callaban, AS. 2005. Long-Term Therapy to Prevent Stroke. J Am Board
Fam Pract. 18: 528 – 540. Kissela, B.M., Khoury, J.K., Kleindorfer, Woo, D., Schneider, Alwell, K., et al. 2005. Epidemiology
of Ischemic Stroke in Patients With Diabetes. The GreaterCincinnatiNorthern Kentucky Stroke Study.
Koren-Morag, N., Goldbourt, U., Tanne, D. 2005. Relation Between the Metabolic Syndrome and Ischemic Stroke or Transient Ischemic Attack. A Prospective Cohort Study in Patients With
Atherosclerotic Cardiovascular Disease. Stroke. 36:1366 – 1371. Lina, Y dan Wijaya, A. 2005. Mekanisme Molekuler Diabetes Tipe 2. Forum Diagnosticum. 2:1 –
15. Luscher, T.F., Creager, M.A. 2003. Diabetes and Vascular Disease. Pathophysiology, Clinical
Consequences, and Medical Therapy: Part II. Circulation. 108: 1655 – 1661. Machfoed, M.H. 2003. The Latest Clinical Epidemiological Data of Ischemic and Hemorrhagic
Stroke Patients in Surabaya and the Surroundings. A Hospital Based Study. Folia Medica Indonesiana.39:242 – 250.
Manji, H., Connolly, S., Dorward, N., Kitcqhen, N., Mehta, A., Wills, A. 2007. Oxford Handbook of Neurology. Oxford University Press. New York.
Mardiyono, B., Moeslichan, Mz. S., Sastroasmoro, S., Budiman, I., Purwanto, S.H. 2002. Perkiraan Besar Sampel. Dalam : Satroasmoro, S., Ismael, S. editor. Dasar-dasar Metodelogi
Penelitian Klinis. Edisi I. Hal. 259 – 287. Bagian Ilmu Kesehatan Anak FK – UI. Jakarta. Marino, P.L. 2007. The ICU Book. Lippincott Williams Wilkins. Philadelphia.
Marshall, S.M., Flyvjerg, A. 2006. Prevention and Early detection of Vascular Complication of
Diabetes.BMJ. 333:475 – 480. Matz, K., Keresztes, K., Tatschl, C., Nowotny, M., Dachenhausen, A., Brainin, M., Toumilehto, J.
2006. Disorder of Glucose Metabolism in Acute Stroke Patients: An underrecognized problem. Diabetes Care. 29:792 – 797.
Megherbi, S., Milan, C., Minier, D., Couvreur, G., Osseby, G., Tilling, K., at al. 2003. Association Between Diabetes and Stroke Subtype on Survival and Functional Outcome 3 Months After
Stroke: Data From the European BIOMED stroke Project. Stroke. 34:688 – 694. Misbach, J. 1999. Stroke Aaspek Diagnostik, Patofisiologi, Menejemen. Balai Penerbit Fakultas
Kedokteran Indonesia. Jakarta.
Roberthus Bangun: Hubungan Kadar Albumn Serum Dan Outcome Fungsional Penderita Stroke Iskemik Dengan Dan Tanpa Diabetes, 2008.
Mulnier, H.E., Seaman, H.E., Raleigh, V.S., Soedamah-Muthu, S.S., Colhoun, H.M., Lawrenson,
R.A., et al. 2006. Risk of Stroke in People With Type 2 Diabetes in the UK: A study using the General Practice Research Database. Diabetologia. 49:2859 – 2865.
Murray, R.K. 2006. Plasma Proteins Immunoglobulins. In: Murray, R.K. Granner, D.K., Rodwell, V.W. eds. Harper’s Illustrated Biochemistry. 27
th
ed. pp.588 – 606. McGraw-Hill. New York. Naik, R.G., Lernmark, A., Palmer, J.P. 2005. The Pathophysiology and Genetic of Type 1 Insulin-
Dependent Diabetes. In: Inzucchi, S., Porte, D., Sherwin, R.S., Baron, A. eds. The Diabetes Mellitus Manual: A Primary Care Companion to Ellenberg Rifkin’s. 6
th
ed. pp.29 – 50. McGraw-Hill. New York.
Nicholson, J.P., Wolmarans, M.R., Park, G.R. 2000. The role of albumin in critical illness. Br J Anaesth. 85:599 – 610.
Paithankar, M.M., and Dabhi, R.D. 2003. Functional Recovery in Ischemic Stroke. Neurol India. 51:414 – 416.
Palesch, Y.Y., Hill, M.D., Ryckborst, K.J., Tamariz, D., Ginsberg, M.D. 2006. The ALIAS Pilot Trial. A dose-Escalation and Safety of Albumin Therapy for Acute Ischemic Stroke – II: Neurologic
Outcome and Efficacy Analysis. Stroke. 37:2107 – 2114. Parelta, R., Rubery, B.A., Guzofski, S. 2006. Hypoalbuminemia. Avialable from:
http:www.emedicine.commedtopic1116.htm .
Rodbard, H.W., Braitwaite, S.S., Blonde, L., Brett, E.M., Cobin, R.H., Handelsman, Y., et al. 2007. American Association of Clinical Endocrinologists Medical Guideline for Clinical Practice for
the Management of Diabetes Mellitus. Endocrine Practice. 13Suppl 1:1 – 68. Ropper, A.H., Brown, R.H. 2005. Adams and Victor’s Principles of Neurology. 8th ed. Mc Graw-
Hill. New York. Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, Alan., Greenlund, K. 2007. Heart Disease and
Stroke Statistics – 2007 Update: A Report From the American Heart Assotiation Statistic Committee and Stroke Statistics Subcommitte. Circulation. 115: 69 – 171.
Rose, C. 2002. Evaluation of Hypoalbuminemia. Avialable from: http:www.hcvma.orgarticlesEvaluation20of20Hypoalbuminemia.PDF
. Ryden, L., Standl, E., Bartnik, M., Van den Barghe, G., Beteridge, J., de Boer, M., et al. 2007.
Guideline on Diabetes, pre-diabetes, and cardiovascular disease. Eropean Heart Journal Supplement 9:3 – 74.
Roberthus Bangun: Hubungan Kadar Albumn Serum Dan Outcome Fungsional Penderita Stroke Iskemik Dengan Dan Tanpa Diabetes, 2008.
Sacco, R.L. dan Boden-Albala, B. 2001. Stroke Risk Factors: Identification and Modification. In: Fisher, M ed Stroke Therapy. 2nd ed. pp. 1 – 23. Butterworth-Heinnemann. Boston.
Sacco, R.L. 2000. Pathogenesis, Classification, and Epidemiology of Cerebrovasculer Disease. In: Rowland, L.P. ed Merrit’s Neurology. 10
th
ed. pp. 217 – 229. Lippincott William Wilkins. Philadelphia.
Sainbury A., Seebass, G., Bansal, A., Young, J.B. 2005. Reliability of the Barthel Index when used with older people. Age and Aging. 34:228 – 232.
Schle, D., Kolb, S.J., Luciano, J.M., Tovar., J.M., Cucchiara, B.L., Liebeskind, D.S., Kasner, S.E. 2003. Utility of the NIH Stroke Scale as a Predictor of Hospital Disposition. Stroke. 34: 134 –
137. Schurr, A. 2002. Lactate, glucose and energy metabolism in the ischemic brain Review.
International Journal of Molecular Medicine. 10:131 – 136. Sjahrir, H. 2003. Stroke Iskemik. Yandira Agung. Medan.
Soertidewi, L. 2007. Peran Unit Stroke Dalam Tata Laksana Stroke Komprehehensif Dalam:
Rasyid, A., Soertidewi, L. eds. Unit Stroke. Manajemen Stroke Secara Komprehensif. pp. 21 – 37. Balai Penerbit Universitas Indonesia. Jakarta.
Stratton, I.M., Adler, A.I., Neil, H.A.W., Matthews, D.R., Manley, S.E., Cull, C.A., Hadden, D., et.al. 2000. Association of glycemia with macrovascular and microvascular complications of type 2
diabetes UKPDS 35: prospective observational study. BMJ. 321:405 – 412. Sulter, G., Steen, C., and Keyser, J.D. 1999. Use of Barthel Index and Modified Rankin Scale in
Acute Stroke Trials. Stroke. 30: 1538 – 1541. Tobe, S.W., McFarlane, P.A., Naimark, D.M. 2002. Microalbuminuria in diabetes mellitus.
Canadian Medical Association Journal .167:499 – 503.
Vancheri, F., Curcio, M., Burgio, A., Salvaggio, S., Gruttadauria, G., Lunetta, M.C., Dovico, R., Alletto, M. 2005. Impaired glucose metabolism in patients with acute stroke and no previous
diagnosis of diabetes mellitus. Q J Med
. 98:871 – 878. Wanke, I.E., dan Wong, N.C.W. 1991. Diabetes Mellitus Decreases the Activity of the Albumin
Promoter in Vitro. The Journal of Biological Chemistry. 266:6068 – 6072.
Roberthus Bangun: Hubungan Kadar Albumn Serum Dan Outcome Fungsional Penderita Stroke Iskemik Dengan Dan Tanpa Diabetes, 2008.
Weimer, C., Kurt, T., Kraywikel, K., Wagner, M., Busse, O., Haberl, R.L., Diener, H.C. 2002. Assesment of Functioning and Disability After Ischemic Stroke. Stroke. 33:2053 – 2059.
William, G.R. 2001. Incidence and Characteristics of Total Stroke in the United States. BMC Neurology. 1:2 – 8.
William, L.S., Yilmaz, E.Y., Yunez, A.M.L. 2000. Retrospective Assessment of Initial Stroke Severity With the NIH Stroke Scale. Stroke. 31: 858 – 862.
Young, F.B., Weir, C.J., Lees, K.R. 2005. Comparison of the National Institutes of Health Stroke Scale With Disability Outcome Measures in Acute Stroke Trials. Stroke. 36:2187 – 2192.
Roberthus Bangun: Hubungan Kadar Albumn Serum Dan Outcome Fungsional Penderita Stroke Iskemik Dengan Dan Tanpa Diabetes, 2008.
SURAT PERSETUJUAN IKUT DALAM PENELITIAN
Saya yang bertanda tangan di bawah ini :
Nama :
Jenis Kelamin :
Umur :
Pekerjaan :
Alamat :
Setelah mendapat keterangan secara terperinci dan jelas mengenai penelitian yang berjudul
“HUBUNGAN KADAR ALBUMIN SERUM DAN OUTCOME FUNGSIONAL STROKE ISKEMIK DENGAN DAN TANPA DIABETES ”
dan setelah mendapat kesempatan mengajukan pertanyaan mengenai gejala sesuatu yang berhubungan dengan penelitian tersebut, maka dengan ini saya
secara sukarela dan tanpa paksaan menyatakan saya ikut dalam penelitian tersebut.
Medan,..……………………..2007
1. 2.
LAMPIRAN 2
LEMBAR PENGUMPUL DATA PENELITIAN
I. IDENTITAS PRIBADI
No. Urut : No. MR :
Tgl MRS : Nama Lengkap : Umur : thn
Jenis kelamin : Pria Wanita Status: Kawin
Tidak kawin Suku bangsa :
Toba Karo Simalungun Mandailing Jawa Nias ............
Roberthus Bangun: Hubungan Kadar Albumn Serum Dan Outcome Fungsional Penderita Stroke Iskemik Dengan Dan Tanpa Diabetes, 2008.
Alamat :
II. HASIL PEMERIKSAAN 1. Saat Masuk Rumah Sakit
1.1. Vital Sign
